Elo Mutual Pension Insurance Co Sells 482 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Elo Mutual Pension Insurance Co lessened its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 4.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,391 shares of the company’s stock after selling 482 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Henry Schein were worth $730,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of HSIC. Amalgamated Bank boosted its stake in shares of Henry Schein by 5.0% in the second quarter. Amalgamated Bank now owns 41,633 shares of the company’s stock valued at $2,669,000 after buying an additional 1,973 shares during the period. Edgestream Partners L.P. bought a new stake in shares of Henry Schein during the 2nd quarter valued at $1,418,000. Dimensional Fund Advisors LP grew its holdings in shares of Henry Schein by 10.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company’s stock worth $104,764,000 after purchasing an additional 149,517 shares in the last quarter. Keene & Associates Inc. increased its position in shares of Henry Schein by 14.3% in the second quarter. Keene & Associates Inc. now owns 5,150 shares of the company’s stock worth $330,000 after purchasing an additional 645 shares during the period. Finally, Thompson Siegel & Walmsley LLC acquired a new position in Henry Schein in the second quarter valued at about $46,683,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of analyst reports. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Barrington Research restated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Friday. Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. Finally, Evercore ISI lowered their price target on Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $77.10.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $71.15 on Friday. The stock’s 50-day moving average is $69.89 and its 200-day moving average is $70.35. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The stock has a market cap of $9.11 billion, a P/E ratio of 24.04, a price-to-earnings-growth ratio of 1.88 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company’s revenue was up .0% on a year-over-year basis. During the same period in the prior year, the company posted $1.31 EPS. Equities research analysts anticipate that Henry Schein, Inc. will post 4.75 earnings per share for the current year.

Insider Buying and Selling

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.14% of the stock is owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.